• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

AI vs. Humans: AI Solution Beats Stanford Radiologists In Chest X-ray Diagnostics Competition

Share:

August 27, 2019

JF Healthcare, a Nanchang, China-based medical diagnostic startup is the first organization in the world to beat Stanford University radiologists in a competition designed by the Stanford Machine Learning group to compare the capability of artificial intelligence (AI) to human experts in interpreting chest x-rays.

The AI team from JF Healthcare recently achieved an average AUC score (a measure of diagnostic accuracy) of 0.926 and is currently ranked No. 1 in the world on Stanford’s CheXpert leaderboard. Significantly, the JF team outperforms all three Stanford radiologists on the test set, demonstrating the role that AI can play in providing precise medical diagnostics, especially in underserved areas of the world, with profound implications for the treatment of lung cancer, tuberculosis and other diseases of the thorax.

JF Healthcare Background

Founded in 2015 by former Siemens healthcare executive Frank Wu, JF offers remote diagnostic services, focusing on chest x-rays, for rural township hospitals in China where certified radiologists are often not available. Its mobile screening truck is expected to screen more than ten provinces in China for tuberculosis by the end of 2019, offering a half-million people the possibility of early detection while preventing the spread of disease to broader populations.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

JF plans to develop a chest x-ray screening product to simultaneously screen for tuberculosis, lung cancer, and pneumonia, covering the major thorax diseases based on more than 300,000 chest x-ray images with curated radiology reports collected from approximately 1,000 township hospitals. The team is hoping to fully leverage the clinical value of chest x-rays through AI and deliver it to the massive township hospital patient population in China where radiologists are most needed.

Why It Matters

“The goal is to be better than the best human in making diagnoses and deliver low-cost care with a level of quality that is equivalent to the best hospitals in the world. To do that, the secret is not math; it’s a huge volume of well-curated data,” said Wu, JF Healthcare’s Founder and CEO. “There are 3 billion people in the world without access to quality healthcare. The first step in remedying this problem is providing extremely accurate diagnostics, which is at the core of our strategy and mission.”

Date: August 27, 2019

Source: HIT Consultant

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • VC Funding in Digital Health Hits $5.1 Billion in 1H 2019VC Funding in Digital Health Hits $5.1 Billion in 1H 2019
  • AI in Pharma and Biomedicine – Analysis of the Top 5 Global Drug CompaniesAI in Pharma and Biomedicine – Analysis of the Top 5 Global Drug Companies
  • Provider Identity API Startup Verifiable Collects $3M Seed FundingProvider Identity API Startup Verifiable Collects $3M Seed Funding
  • Nanox and Usard Expand Their Radiology Diagnostic Partnership; Sera Prognostics and Anthem Launch a Neonatal Outcomes Study; and More Digital Health DealsNanox and Usard Expand Their Radiology Diagnostic Partnership; Sera Prognostics and Anthem Launch a Neonatal Outcomes Study; and More Digital Health Deals
  • Glaucoma Pharmaceutical Market Research Report 2022 By Manufacturers, Regions, Types and ApplicationsGlaucoma Pharmaceutical Market Research Report 2022 By Manufacturers, Regions, Types and Applications
  • Lifepoint Informatics Launches App for DrChrono EHR Users to Manage Lab ReportsLifepoint Informatics Launches App for DrChrono EHR Users to Manage Lab Reports
  • Start-up Raises €1.8m to Develop Technology to Combat LonelinessStart-up Raises €1.8m to Develop Technology to Combat Loneliness
  • MiRXES to Manufacture and Distribute Fortitude Kit SARS-CoV-2 RT-PCR TestMiRXES to Manufacture and Distribute Fortitude Kit SARS-CoV-2 RT-PCR Test

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications